Giardia

Giardia
Name	Giardia
Caption	Scanning electron micrograph of Giardia lamblia
Field	Infectious disease, Parasitology
Symptoms	Diarrhea, abdominal cramps, bloating, weight loss
Causes	Giardia lamblia (G. duodenalis, G. intestinalis)
Risks	Contaminated water, poor sanitation, travel
Diagnosis	Microscopy, antigen testing, PCR
Prevention	Water purification, hand hygiene
Treatment	Metronidazole, Tinidazole, Nitazoxanide
Frequency	Global, ~200 million symptomatic cases/year

Giardia. It is a genus of flagellated protozoan parasites that inhabit the small intestine of a wide range of vertebrate hosts, including humans. The species Giardia lamblia (also known as G. duodenalis or G. intestinalis) is a major cause of waterborne diarrheal disease worldwide, known as giardiasis. This parasite was first observed by Antonie van Leeuwenhoek in his own stool in 1681 and later described in more detail by Alfred Mathieu Giard and Vilem Lambl.

Biology and morphology

The life cycle involves two main stages: the infectious cyst and the replicative, motile trophozoite. The trophozoite is characterized by a distinctive pear-shaped, bilaterally symmetrical body, typically 10-20 micrometers in length. It possesses four pairs of flagella and a prominent adhesive disc composed of microtubules and giardin proteins, which allows it to attach to the enterocytes of the duodenum. The parasite has a simple, anaerobic metabolism and lacks mitochondria and a classical Golgi apparatus, instead possessing mitosomes. Its genome is relatively compact, and studies of its cytoskeleton have been important in understanding eukaryotic cell evolution.

Life cycle and transmission

Infection begins with the ingestion of the environmentally resistant, quadrinucleate cyst, which can survive for weeks in cold water. Excystation occurs in the stomach and duodenum, triggered by gastric acid and pancreatic enzymes, releasing two trophozoites. These trophozoites multiply by longitudinal binary fission and colonize the lumen of the proximal small intestine. As trophozoites pass down the colon, they encyst in response to bile salts and cholesterol starvation, forming new cysts that are excreted in feces. Primary transmission routes include ingestion of contaminated drinking water from sources like lakes and rivers, consumption of contaminated food, and direct fecal-oral contact, particularly in settings like childcare centers.

Pathogenesis and clinical features

Disease results from a combination of direct mucosal damage and functional changes, though the exact mechanisms are not fully understood. Trophozoite attachment via the adhesive disc can cause villous blunting and crypt hyperplasia, leading to malabsorption. Symptoms range from asymptomatic carriage to acute or chronic diarrhea, characterized by foul-smelling, greasy stools, abdominal distension, flatulence, nausea, and weight loss. The incubation period is typically 1-2 weeks. Chronic infection can contribute to post-infectious irritable bowel syndrome and failure to thrive in children. The immune response involves IgA and cell-mediated immunity, but the parasite employs antigenic variation of variant-specific surface proteins to evade the host immune system.

Diagnosis and detection

Diagnosis traditionally relies on microscopic identification of cysts or trophozoites in stool samples, often using concentration techniques like the formalin-ethyl acetate method and stains such as trichrome. Due to intermittent shedding, examination of multiple samples over several days may be necessary. More sensitive and specific methods include direct fluorescent antibody tests and detection of parasite antigens using enzyme immunoassay techniques. Molecular diagnostics like polymerase chain reaction and genotyping are used in reference laboratories and for outbreak investigations to identify specific assemblages with zoonotic potential.

Treatment and prevention

The nitroimidazole class of drugs, particularly metronidazole and tinidazole, are first-line therapies. Nitazoxanide is an effective alternative, approved for use in children. Albendazole and quinacrine are also used in some regimens. Drug resistance, though reported, is not widespread. Prevention focuses on interrupting transmission through proper treatment of drinking water via filtration or boiling, practicing good hand hygiene, and safe disposal of sewage. Travelers to endemic regions, such as backpackers in the Rocky Mountains, are advised to avoid untreated water. No effective vaccine exists for humans, though veterinary vaccines are available for cats and dogs.

Epidemiology

Giardiasis is found globally, with higher prevalence in regions with inadequate sanitation and limited access to clean water, including parts of Asia, Africa, and Latin America. In the United States, it is a commonly reported intestinal parasitic disease to the Centers for Disease Control and Prevention, with outbreaks often linked to contaminated community water systems, recreational water venues like swimming pools, and institutional settings. It is a recognized cause of "traveler's diarrhea" and is considered a neglected tropical disease. Zoonotic transmission from beavers, livestock, and companion animals contributes to the environmental reservoir, highlighting its importance in One Health initiatives.

Category:Parasitic diseases Category:Waterborne diseases Category:Intestinal infectious diseases